Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer - Top-Institutions - MDSpire

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

  • By

  • Zhoujunyi Tian

  • Haoshuai Yang

  • Jin Zhang

  • Qiduo Yu

  • Deruo Liu

  • Meng Yang

  • Zhenrong Zhang

  • Chaoyang Liang

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    China-Japan Friendship Hospital
    China-Japan Friendship Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Trinity St. James’s Cancer Institute
    Trinity St. James’s Cancer Institute

    Derry, Northern Ireland

    Key Differentiators

    • Oncology

  • #4

    Trinity College Dublin
    Trinity College Dublin

    Dublin, Ireland

    Key Differentiators

    • Oncology

  • #5

    University of Milan
    University of Milan

    Milan, Lombardy

    Key Differentiators

    • Oncology

Original Source(s)

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

  • by Zhoujunyi Tian, Haoshuai Yang, Jin Zhang, Qiduo Yu, Deruo Liu, Meng Yang, Zhenrong Zhang, Chaoyang Liang

  • May 28, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

Biotech exec Jeremy Levin on the industry’s strategic turning point